This partnership
is personal

Today’s genomic solutions for tomorrow’s cancer breakthroughs

Cancer Genomics Research

Illumina next-generation sequencing (NGS) and microarray technologies represent the gold standard in quality worldwide—and account for ~90% of the world’s sequencing data.* Innovative, intuitive, and completely integrated, our sample-to-data solutions empower your lab to keep ahead of the curve in the rapidly evolving genomics revolution. So you’ll be better able to perform the world-class research you strive for—with the goal of uncovering new insights into the biology of cancer that can lead to meaningful advances in personalized medicine.

Our comprehensive product offerings support multiple cancer research applications, including studies of DNA, RNA, epigenetics, and more. Our range of sequencers can be scaled to meet your needs—from powerful, yet personal, benchtop models to versatile, high-throughput systems. With intuitive data analysis and management capabilities and unsurpassed customer support, we can deliver the answers you seek—quickly, accurately, and cost-effectively.

Oncology

NGS technology has accelerated the discovery of variants associated with cancer. Some of these research discoveries became the basis for companion diagnostics and laboratory developed tests (LDT) now in use in molecular diagnostic laboratories worldwide. We spoke with key opinion leaders about the ongoing challenges and potential of NGS in oncology testing.

Read Interview
The Changing Landscape of NGS Implementation in Molecular Diagnostic Laboratories
Driving the Global Development of Cancer Therapy Selection
Driving the Global Development of Cancer Therapy Selection

Studies from Japan and Belgium seek to advance precision medicine in oncology

Read Article
Using Analytics to Improve Cancer Diagnosis and Therapy Selection
Using Analytics to Improve Cancer Diagnosis and Therapy Selection

Developing and automating best-practice workflows that make analyzing, processing, and disseminating genomic data accessible to researchers and clinicians.

Read Interview
Introducing the Illumina–University of Melbourne Genomics Hub
Introducing the Illumina–University of Melbourne Genomics Hub

Positioning Australia at the forefront of healthcare innovation

Read Article
Image
Genomic Technologies for Cancer Research

Learn the numerous ways that genomic technologies can be applied to tumor biology.

Read Overview
Image
Cancer Research Review

An overview of recent cancer genomics research publications featuring Illumina technology.

Read Review
Interested in receiving newsletters, case studies, and information on cancer genomics?
Sign Up
Image
Insights into Leukemia and Lymphoma

Munich Leukemia Laboratory is using NGS to gain a better understanding of leukemia and lymphoma subtypes and discover new therapeutic pathways.

View Video
Cancer Research Webinar
Educational Webinars

Explore a variety of webinars on topics ranging from cancer research to NGS data analysis, microbiome studies, and more.

View Webinars
Image
Sequencing Analysis of Tissue Samples: Fresh Frozen vs. FFPE

A researcher from Massachusetts General Hospital compares sequencing results from FFPE and fresh-frozen tumor samples.

View Video
References

*Data on file based on a 2013 study.